Duloxetine for Menopausal Depression.
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Menopause
- Focus Therapeutic Use
- 18 Jun 2014 Status changed from active, no longer recruiting to completed.
- 14 May 2012 Planned end date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 14 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.